The COVID-19 pandemic has affected workplaces across the world, leaving employers scrambling to find safe ways to continue their operations while protecting their employees. At MDGuidelines, our team now works remotely, so we haven’t missed a beat. Because we know that evidence-based treatment guidelines are now more important than ever, we’ve been working from our home offices to ensure that our content reflects the latest clinical research to help you make the best decisions in these uncertain times.
The American College of Occupational and Environmental Medicine (ACOEM) Practice Guidelines, available only to MDGuidelines subscribers, are the gold standard in effective treatment of occupational injuries and illnesses. Our research team and physician panel members have evaluated thousands of clinical trials to provide you with the most current evidence-based recommendations to guide clinical diagnosis and treatment. So far in 2020, we have published three brand-new guidelines (including a COVID-19 guideline, which is freely available to subscribers and non-subscribers alike at info.mdguidelines.com) and two focused updates of previously published guidelines. These targeted updates involve a thorough search for new high-quality studies that support or transform existing knowledge on key diagnostic interventions or treatments.
Our MDGuidelines medical topics provide a comprehensive resource that encompasses more than 1,200 medical conditions, injuries, illnesses, and surgical procedures. MDGuidelines topics undergo extensive medical accuracy review with members of our Medical Advisory Board, and are updated on a rolling cycle to provide real-world return-to-activity timelines. The most recent content update, published in June 2020, included 114 new and updated duration tables in more than 160 topics.
DART and Formulary
Two tools that are exclusive to MDGuidelines—the Diagnosis and Related Treatments (DART) tool and the Formulary—concisely aggregate diagnostic and treatment recommendations from the ACOEM guidelines, including links to supporting evidence. These tools have been updated along with our ACOEM Practice Guidelines to provide new and revised recommendations for Depressive Disorders, Antiemetics, and Occupational Asthma.
Compiling and sharing all of these updates and new guidelines the MDGuidelines team has created during a time of unprecedented disruption makes me proud. Stay well and let’s all continue to do good work together.